Edition:
United Kingdom

Acceleron Pharma Inc (XLRN.OQ)

XLRN.OQ on NASDAQ Stock Exchange Global Market

46.50USD
18 Jul 2018
Change (% chg)

-- (--)
Prev Close
$46.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
126,146
52-wk High
$50.00
52-wk Low
$29.59

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.62 December 19 Jul 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 5 8 8 8
(3) HOLD 5 2 2 2
(4) UNDERPERFORM 0 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.15 2.07 2.07 2.07

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 10 6.77 27.88 2.70 4.18
Quarter Ending Dec-18 10 10.63 28.74 2.40 4.18
Year Ending Dec-18 12 25.02 42.00 12.10 34.10
Year Ending Dec-19 13 65.70 170.19 17.40 107.33
Earnings (per share)
Quarter Ending Sep-18 13 -0.62 -0.18 -0.83 -0.71
Quarter Ending Dec-18 13 -0.58 -0.07 -0.95 -0.74
Year Ending Dec-18 13 -2.42 -1.82 -3.10 -2.16
Year Ending Dec-19 14 -1.90 -0.30 -3.48 -1.01

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 4.21 3.23 0.98 23.22
Quarter Ending Dec-17 3.60 3.70 0.10 2.90
Quarter Ending Sep-17 4.98 3.01 1.97 39.50
Quarter Ending Jun-17 3.69 3.06 0.64 17.21
Quarter Ending Mar-17 3.91 3.70 0.20 5.13
Earnings (per share)
Quarter Ending Mar-18 -0.64 -0.58 0.06 -9.88
Quarter Ending Dec-17 -0.61 -0.62 0.01 -2.29
Quarter Ending Sep-17 -0.64 -0.65 0.01 -1.61
Quarter Ending Jun-17 -0.62 -0.68 0.06 -8.80
Quarter Ending Mar-17 -0.54 -0.66 0.12 -22.72

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 6.77 6.77 6.77 6.77 4.18
Quarter Ending Dec-18 10.63 10.63 10.63 10.63 4.18
Year Ending Dec-18 25.02 25.02 26.05 24.45 34.10
Year Ending Dec-19 65.70 65.86 67.83 67.83 107.33
Earnings (per share)
Quarter Ending Sep-18 -0.62 -0.62 -0.60 -0.60 -0.71
Quarter Ending Dec-18 -0.58 -0.58 -0.55 -0.56 -0.74
Year Ending Dec-18 -2.42 -2.43 -2.35 -2.38 -2.16
Year Ending Dec-19 -1.90 -1.90 -1.85 -1.84 -1.01

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 1 0 5
Earnings
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 1 0 1
Year Ending Dec-18 1 0 0 2
Year Ending Dec-19 0 0 0 4